API tools faq
paste
callmedougan

2018.11.18 - Units List and Evidence Requirements

callmedougan
Nov 21st, 2018 (edited)
649
0
Never
Add comment
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 4.45 KB | None | 0 0
raw download clone embed print report
  1. 21/11/2018 Units List
  2.  
  3. Whats left to achieve
  4.  
  5. Details of what Andrew needs to achieve to complete qualification "Pearson Edexcel Level 3 Diploma for Health Screeners"
  6.  
  7.  
  8.  
  9. Unit 13 Health Screening Principles
  10.  
  11. Learning Outcome 1 : Understand the policies, procedures and principles of health screening
  12.  
  13. 01.1 Define the following terms related to Health Screening:
  14.  
  15. Prevalence
  16. Sensitivity
  17. Specificity
  18. False positives
  19. False negatives
  20.  
  21. 01.2 Describe what is meant by a screening pathway
  22.  
  23. 01.3 List the current NHS Screening Programmes
  24.  
  25. 01.4 Explain the conditions needed to be met before a new screening programme is approved to be rolled out nationally
  26.  
  27. 01.5 Outline health screening policies and procedures within own area of work
  28.  
  29. 01.6 Explain the difference between screening and diagnosis
  30.  
  31. 01.7 Explain the benefits and limitations of NHS screening programmes
  32.  
  33.  
  34. Learning Outcome 2 : Be able to follow the requirements for informed choice and consent in health screening
  35.  
  36. 02.1 Summarise the legal requirements regarding:
  37.  
  38. Data Protection
  39. Confidentiality
  40.  
  41. 02.2 Explain what is meant by consent
  42.  
  43. 02.3 Explain the legal principles of obtaining consent
  44.  
  45. 02.4 Explain what is meant by informed choice
  46.  
  47. 02.5 Explain why informed choice for individuals is important regarding screening
  48.  
  49. 02.6 Explain how informed choice is facilitated in screening
  50.  
  51. 02.7 Explain the issues surrounding individual consent prior to screening
  52.  
  53. 02.8 Explain the role of the screener in facilitating informed choice and gaining consent
  54.  
  55. 02.9 Explain the individual’s right to exercise choice in screening
  56.  
  57. 02.12 Describe the reasons why individuals may withdraw their consent
  58.  
  59.  
  60. Learning Outcome 3 : Understand the impact screening may have on individuals
  61.  
  62. 03.1 Describe the impact screening may have on individuals and their families
  63.  
  64. 03.2 Describe the factors that could lead to individuals declining the offer of screening
  65.  
  66. 03.3 Describe the responsibilities of health care staff in ensuring individuals are looked after along the whole screening pathway
  67.  
  68.  
  69. Learning Outcome 4 : Understand the importance of quality assurance, standards and key performance indicators in health screening
  70.  
  71. 04.1 Describe the internal and external quality assurance policies and procedures for own screening programme
  72.  
  73. 04.2 Explain the importance of quality assurance and standards in health screening
  74.  
  75. 04.3 Explain the importance of own programme’s key performance indicators
  76.  
  77. 04.4 Summarise the importance of failsafe systems within health screening
  78.  
  79. 04.5 Explain the importance of maintaining accurate records of the screening cohort
  80.  
  81.  
  82. Learning Outcome 5 : Understand the importance of clinical governance within own area
  83.  
  84. 05.1 Explain what is meant by clinical governance
  85.  
  86. 05.2 Explain the following within own role:practice limitations scope of practice
  87.  
  88.  
  89.  
  90.  
  91. Unit 18 Prepare For Diabetic Retinopathy Screening
  92.  
  93. Learning Outcome 2 : Understand the ways in which screening is affected by individual needs
  94.  
  95. 02.1 Explain how the following factors may influence the examination process:
  96.  
  97. age
  98. cultural
  99. language
  100. physical ability
  101. cognitive ability
  102.  
  103. 02.2 Describe the importance of privacy during a retinal screen
  104.  
  105.  
  106. Learning Outcome 3 : Understand the purpose of visual acuity measurement
  107.  
  108. 03.1 Explain why the accurate measurement and recording of visual acuity should be used in a National screening programme for diabetic retinopathy
  109.  
  110.  
  111. Learning Outcome 5 : Understand the purpose of dilatation of the pupils and the action and contra-indications of drops
  112.  
  113. 05.1 Explain the reasons for pupil dilatation for diabetic retinopathy screening
  114.  
  115. 05.2 Explain the action of mydriatic eye drops and contra-indications to their use
  116.  
  117. 05.3 Identify situations in which pupil dilatation is contra-indicated
  118.  
  119.  
  120.  
  121.  
  122. Unit 21 Detect Retinal Disease and Classify Diabetic Retinopathy
  123.  
  124. A5082992: This unit must be assessed in line with Skills for Health Assessment Principles.
  125.  
  126.  
  127. Learning Outcome 4 : Understand the Grading pathway and related quality assurance
  128.  
  129. 21.4.4 Assess how own role influences the ability of the screening programme to meet the National performance indicators
  130.  
  131.  
  132.  
  133.  
  134.  
  135.  
  136.  
  137.  
  138.  
  139.  
  140.  
  141. https://pqs.pearson.com/ePortfolio/ePortfolio/GapAnalysis/PrintWithER?qualificationId=x1ee8a62cb056487e&userId=x8f0e9e1c41effa08 2/2
Advertisement
Add Comment
Please, Sign In to add comment
Public Pastes
We use cookies for various purposes including analytics. By continuing to use Pastebin, you agree to our use of cookies as described in the Cookies Policy.  OK, I Understand
Not a member of Pastebin yet?
Sign Up, it unlocks many cool features!